These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


545 related items for PubMed ID: 24998692

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L, Morana G, Kirchin MA, Schneider G.
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [Abstract] [Full Text] [Related]

  • 5. Contrast-enhanced MR enterography as a stand-alone tool to evaluate Crohn's disease in a paediatric population.
    Spieler B, Hindman N, Levy J, Zabrieski K, Sahlein D, Seuss C, Kim S.
    Clin Radiol; 2013 Oct; 68(10):1024-30. PubMed ID: 23796211
    [Abstract] [Full Text] [Related]

  • 6. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
    Laghi A, Paolantonio P, Iafrate F, Borrelli O, Dito L, Tomei E, Cucchiara S, Passariello R.
    Radiol Med; 2003 Oct; 106(1-2):18-27. PubMed ID: 12951547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings.
    Ergen FB, Akata D, Sarikaya B, Kerimoglu U, Hayran M, Akhan O, Hussain HK.
    J Comput Assist Tomogr; 2008 Oct; 32(1):54-60. PubMed ID: 18303288
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
    Udayasankar UK, Martin D, Lauenstein T, Rutherford R, Galloway J, Tudorascu D, Sitaraman SV.
    J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
    Kim TK, Lee KH, Jang HJ, Haider MA, Jacks LM, Menezes RJ, Park SH, Yazdi L, Sherman M, Khalili K.
    Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
    [Abstract] [Full Text] [Related]

  • 18. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN, Sigeti JS.
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [Abstract] [Full Text] [Related]

  • 19. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.